19.05.2021 | TopNews Prof. Dr. Roman-Ulrich Müller Prof. Dr. Silvia von Karstedt
This year, the Cologne Theme Weeks start from May 25 - June 25 under the motto "The new normal - seizing opportunities and shaping the future". The topics and formats will be presented by the member institutions of the Kölner Wissenschaftsrunde (KWR), in which CECAD is also represented.
Talks are in German.
People with rare diseases often face special challenges. Who knows the diagnosis? How do I find an expert? Currently, COVID-19 is bringing some of the issues even more to the forefront for those affected, but also for those providing care and conducting research. How can care be provided at a distance by expert centers? Who has the technical expertise? How does it work with bureaucracy in the health care system? Research in the home office? Prof. Müller and Prof. Schermer are experts in the field of rare kidney diseases. These topics will be discussed and debated.
A vaccine in less than a year. A historic amount of time for vaccine development. But why did it happen so quickly? What research could be drawn on? Every day, almost half a million scientists conduct research in Germany. This makes the Federal Republic the third largest research country in the world. What do scientists do all day? What challenges do they face in their research, but also in politics? Dr. Silvia von Karstedt, a cancer researcher at the CECAD Cluster of Excellence for Aging Research at the University of Cologne, provides answers in an interview.
As the SARS Cov-2 infection progresses, many questions arise. What are the characteristics of the virus? Who is really at risk of experiencing a bad outcome? Why do older people suffer high mortality rates? Will vaccines work? What are the protective factors against adverse courses? How to protect against loss of function, reinfection, long-term COVID? What is the impact of COVID on isolation, cognitive impairment, multimorbidity, depression, anxiety? All protective strategies against COVID to improve resilience are those that can simultaneously maintain healthy and active aging. Key strategies are discussed.
March 2020: the Sars-CoV-2 coronavirus has arrived in Europe, and fears of overcrowded emergency rooms are also rising in Cologne. For scientists of the Nephrolab at the Cologne Cluster of Excellence for Aging Research CECAD and the University Hospital Cologne, this is the starting signal for a new project - the development of an innovative corona rapid test. The goal: a quick and easy detection of the virus with the accuracy of a PCR test. The test will be able to be performed on site and without trained personnel and will accompany the way back to "normality".